Analyst Price Target is $3.00
▲ +280.28% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Allurion Technologies in the last 3 months. The average price target is $3.00, with a high forecast of $3.00 and a low forecast of $3.00. The average price target represents a 280.28% upside from the last price of $0.79.
Current Consensus is
Hold
The current consensus among 3 polled investment analysts is to hold stock in Allurion Technologies. This rating has held steady since September 2025, when it changed from a Moderate Buy consensus rating.
Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.
Read More